Site Reference ID/Investigator# 2626 — Boston, Massachusetts

Site Reference ID/Investigator# 2626 is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 2626 has participated in 1 clinical trials.

Therapeutic areas: Small Cell Lung Cancer, Small Cell Lung Carcinoma.

Sponsors: AbbVie (prior sponsor, Abbott).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 2626?

Site Reference ID/Investigator# 2626 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 2626 conducted?

Site Reference ID/Investigator# 2626 has 1 clinical trials on record. Their work covers Small Cell Lung Cancer, Small Cell Lung Carcinoma.

Is Site Reference ID/Investigator# 2626 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator# 2626 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 2626?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.